Nomad Power Solutions NMAD
NASDAQ NMAD
$3.71 +0.00 (+0.00%)
At close: Sep 10, 2026 · 4:00 PM EDT

Nomad Power Solutions (NMAD) Non Operating Interest Expenses (2021 - 2026)

Nomad Power Solutions (NMAD) posted Non Operating Interest Expenses of $851.0 for Q2 2026, down 77.34% on a QoQ basis from $3756.0 in Q4 2025, and down 52.98% year-over-year from $1810.0 in Q2 2025.

Analysis

Nomad Power Solutions (NMAD) Non Operating Interest Expenses (2021 - 2026) Analysis & Trends

Nomad Power Solutions has reported Non Operating Interest Expenses for 6 years, with the latest figure at $851.0 in Q2 2026.

  • On a quarterly basis, Non Operating Interest Expenses fell 52.98% year-over-year to $851.0 in Q2 2026; TTM through Jun 2026 was $6874.0, a 34.07% decrease from a year earlier, with the FY2025 full-year figure at $9158.0, down 45.56% from the prior year.
  • Non Operating Interest Expenses was $851.0 for Q2 2026 at Nomad Power Solutions, down from $3756.0 in the prior quarter.
  • The five-year high for Non Operating Interest Expenses was $10145.0 in Q4 2023, with the low at $279.0 in Q3 2023.
  • Average Non Operating Interest Expenses over 5 years is $3055.2, with a median of $2494.0 recorded in 2022.
  • The sharpest annual moves came in 2023 and 2024: Non Operating Interest Expenses tumbled 86.83% in 2023, then jumped 275.99% in 2024.
  • Over 5 years, Non Operating Interest Expenses stood at $3635.0 in 2022, then surged by 179.09% to $10145.0 in 2023, then sank by 56.31% to $4432.0 in 2024, then decreased by 15.25% to $3756.0 in 2025, then sank by 77.34% to $851.0 in 2026.
  • The last three Non Operating Interest Expenses figures came in at $851.0 (Q2 2026), $3756.0 (Q4 2025), and $457.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 673.00 Mn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 247.00 Mn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 11.00 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -1.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 82.05 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Nomad Power Solutions 49.59 Mn 49.59 Mn - 851.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 851.00
Dec 31, 2025 3,756.00
Sep 30, 2025 457.00
Jun 30, 2025 1,810.00
Mar 31, 2025 3,135.00
Dec 31, 2024 4,432.00
Sep 30, 2024 1,049.00
Jun 30, 2024 4,154.00
Mar 31, 2024 7,186.00
Dec 31, 2023 10,145.00
Sep 30, 2023 279.00
Jun 30, 2023 1,948.00
Mar 31, 2023 3,861.00
Dec 31, 2022 3,635.00
Sep 30, 2022 2,119.00
Jun 30, 2022 627.00
Mar 31, 2022 2,494.00
Dec 31, 2021 4,470.00
Jun 30, 2021 845.00
Mar 31, 2021 2,099.00